Prevalence of PALB2 mutations in Australian familial breast cancer cases and controls-Reference-Cited by-同舟云学术

Prevalence of PALB2 mutations in Australian familial breast cancer cases and controls

Published:2015-08-19 Issue:1 Volume:17 Page:
ISSN:1465-542X
Container-title:Breast Cancer Research
language:en
Short-container-title:Breast Cancer Res

Author:

Thompson Ella R., ,Gorringe Kylie L.,Rowley Simone M.,Wong-Brown Michelle W.,McInerny Simone,Li Na,Trainer Alison H.,Devereux Lisa,Doyle Maria A.,Li Jason,Lupat Richard,Delatycki Martin B.,Mitchell Gillian,James Paul A.,Scott Rodney J.,Campbell Ian G.

Funder

Victorian Breast Cancer Research Consortium

National Health and Medical Research Council

National Breast Cancer Foundation

Publisher

Springer Science and Business Media LLC

Link

http://link.springer.com/content/pdf/10.1186/s13058-015-0627-7.pdf

Reference57 articles.

1. Xia B, Dorsman JC, Ameziane N, de Vries Y, Rooimans MA, Sheng Q, et al. Fanconi anemia is associated with a defect in the BRCA2 partner PALB2. Nat Genet. 2007;39:159–61. doi: 10.1038/ng1942 .

2. Reid S, Schindler D, Hanenberg H, Barker K, Hanks S, Kalb R, et al. Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer. Nat Genet. 2007;39:162–4. doi: 10.1038/ng1947 .

3. Rahman N, Seal S, Thompson D, Kelly P, Renwick A, Elliott A, et al. PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene. Nat Genet. 2007;39:165–7. doi: 10.1038/ng1959 .